Despite this escalating demand for popular GLP-1 drugs, the prices for some of these products are actually dropping. Dr.

Over half of American adults are eligible for semaglutide, but insurance and other barriers make it hard for people to access ...

Joe Breen, 38, is one of thousands of people whose experiences with GLP-1s such as Ozempic and Wegovy have radically changed their relationship with alcohol. Are these drugs the future for treating ...

Novo Nordisk’s (NVO) semaglutide is a GLP-1 weight loss drug marketed as three separate brand name medications, Ozempic, Wegovy, and Rybelsus. Novo’s Wegovy competes with Eli Lilly’s (LLY) Zepbound.

Weight-loss drugs are typically not covered by private insurance plans, and in late November, President Joe Biden proposed ...

Barriers to accessing GLP-1 medications are beginning to break down as drug manufacturers, insurers, and lawmakers look to expand availability, lower costs, and address continued high demand.

Novo Nordisk NVO announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency ...

Type 2 diabetes patients may have a lower risk of venous thromboembolism (VTE) when treated with a GLP-1 receptor agonist, ...

A $29 entry price helps provide accessibility for people pursuing weight loss goalsService includes all features of Noom Med ...

Meds like Wegovy are all over the news. But are they right for you, especially if you’re older than the average user?

Nurse practitioner Tim Nicaise tried everything to lose weight without success. Then his doctor prescribed the drug Contrave ...

The Biden administration has called for Medicare and Medicaid to expand coverage of weight-loss drugs for people struggling ...